Crystalvue Medical Corporation

Research Crystalvue Medical Corporation (6527.TWO) on Bullrun: market cap TWD 1.84B, P/E 12.6, dividend yield 4.0%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is TWD 1.84B; P/E is 12.6; dividend yield is 4.0%.

Peer valuation comparison

Latest P/E is 12.59x versus a Healthcare sector median of 21.8x (42.2% below).

Latest dividend yield is 3.98% versus a Healthcare sector median of 2.4% (65.8% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18TWD 1.84B12.64.0%2.9

Dividend history

Latest trailing dividend snapshot: annual dividend/share 2.9 TWD, yield 4.0%.

About Crystalvue Medical Corporation

Crystalvue Medical Corporation manufactures and sells medical devices worldwide. The company offers optical coherence tomography, retinal cameras, tonometers, lens edgers, and gastroenterology supplies, as well as ODM/OEM services for automated nucleic acid extraction instrument and PCR system. It also sells minimal invasive endoscopic instrument supplies. The company was founded in 2009 and is based in Taoyuan City, Taiwan.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Crystalvue Medical Corporation's market cap?

Crystalvue Medical Corporation's market capitalization is TWD 1.84B.

What is Crystalvue Medical Corporation's P/E ratio?

Crystalvue Medical Corporation's price-to-earnings (P/E) ratio is 12.6.

Does Crystalvue Medical Corporation pay a dividend?

Crystalvue Medical Corporation has a dividend yield of 4.0%.

What does Crystalvue Medical Corporation do?

Crystalvue Medical Corporation manufactures and sells medical devices worldwide. The company offers optical coherence tomography, retinal cameras, tonometers, lens edgers, and gastroenterology supplies, as well as ODM/OEM services for automated nucleic acid extraction instrument and PCR system. It also sells minimal invasive endoscopic instrument supplies. The company was founded in 2009 and is based in Taoyuan City, Taiwan.